Oak Ridge Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Sell
1,330
-104
-7% -$58.3K 0.04% 136
2026
Q1
$806K Hold
1,434
0.05% 133
2025
Q4
$970K Sell
1,434
-87
-6% -$59.2K 0.06% 129
2025
Q3
$972K Buy
1,521
+4
+0.3% +$2.43K 0.06% 123
2025
Q2
$814K Sell
1,517
-229
-13% -$110K 0.06% 124
2025
Q1
$733K Sell
1,746
-44
-2% -$19.1K 0.06% 126
2024
Q4
$740K Sell
1,790
-4
-0.2% -$1.75K 0.06% 129
2024
Q3
$906K Sell
1,794
-41
-2% -$19.9K 0.08% 117
2024
Q2
$894K Buy
1,835
+4
+0.2% +$2.01K 0.09% 118
2024
Q1
$989K Sell
1,831
-211
-10% -$115K 0.1% 120
2023
Q4
$1.13M Sell
2,042
-121
-6% -$56.8K 0.13% 117
2023
Q3
$946K Sell
2,163
-5
-0.2% -$2.49K 0.12% 119
2023
Q2
$1.09M Sell
2,168
-32
-1% -$15.3K 0.13% 121
2023
Q1
$1.1M Buy
2,200
+174
+9% +$83.3K 0.15% 121
2022
Q4
$827K Buy
+2,026
New +$786K 0.12% 126

Other funds holding IDXX

Oak Ridge Investments's IDXX Position: Q2 2026 in Review

Oak Ridge Investments reduced its Idexx Laboratories (IDXX) stake by 7.3% in Q2 2026, selling an estimated $58.3K and leaving 1,330 shares worth $700K. The position accounts for 0.04% of the portfolio, ranked #136.

Oak Ridge Investments first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.13M in Q4 2023. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Oak Ridge Investments held 1,330 shares of Idexx Laboratories worth $700K as of Q2 2026.
  • Oak Ridge Investments sold 104 Idexx Laboratories shares in Q2 2026, an estimated $58.3K.
  • Idexx Laboratories made up 0.04% of Oak Ridge Investments's portfolio in Q2 2026, its #136 holding.
  • Oak Ridge Investments first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Oak Ridge Investments's Idexx Laboratories position peaked at $1.13M in Q4 2023.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.